- Acute Myeloid Leukemia (AML)
- Bladder Cancer
- Breast Cancer
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Colon Cancer
- Esophageal Cancer
- Heart Failure
- Hypertrophic Cardiomyopathy (HCM)
- Liver Cancer
- Lung Cancer
- Melanoma
- Multiple Myeloma
Multiple Myeloma
Discover local Multiple Myeloma resources:
- Multiple Sclerosis (MS)
- Myelodysplastic Syndrome (MDS)
- Myeloproliferative Neoplasms
- Non-Hodgkin Lymphoma
- Ovarian Cancer
Ovarian Cancer
Discover local Ovarian Cancer resources:
- Prostate Cancer
- Psoriasis
- Diseases
- Acute Myeloid Leukemia (AML)
- Bladder Cancer
- Breast Cancer
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Colon Cancer
- Esophageal Cancer
- Liver Cancer
- Lung Cancer
- Melanoma
- Multiple Myeloma
Multiple Myeloma: Main Page
- Myelodysplastic Syndrome (MDS)
- Myeloproliferative Neoplasms
- Ovarian Cancer
Ovarian Cancer: Main Page
View Ovarian Cancer Main PageDiscover Local Ovarian Cancer resources:
- Non-Hodgkin Lymphoma
- Prostate Cancer
- Cold Agglutinin Disease (CAD)
- Heart Failure
- Hypertrophic Cardiomyopathy (HCM)
- Mental Health
- Multiple Sclerosis (MS)
- Psoriasis
- Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Von Hippel-Lindau Disease
- Close the Gap
- SurvivorNetTV
- Clinical Trials
- News
- About Us
- Newsletters and Guides
- SN Connect
- Contact Us
- Studios
- Sign Up
- Log In
Dr. Patrick Forde
Thoracic Oncologist
Johns Hopkins Medicine
Dr. Patrick Forde is director of the Thoracic Oncology Clinical Research Program and associate professor of oncology at Johns Hopkins. He treats patients with lung cancer, mesothelioma, and other thoracic cancers.
Dr. Forde received his bachelor of medicine and surgery degree from the Royal College of Surgeons in Ireland, and did residencies at the Royal College of Physicians Ireland, the Mater Misericordiae University Hospital, and Beaumont Hospital. He completed his fellowship in oncology at Johns Hopkins in 2014.
In his research, Dr. Forde studies the role of immunotherapy for early-stage lung cancer. He has led international phase 2 and 3 clinical trials of new immunotherapy approaches for lung cancer and mesothelioma.
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.
Sign In
Please sign in to save videos. Don't have an account? Register